-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Pliant Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2019 to 2024.
- Pliant Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $513 K, a 13.5% increase year-over-year.
- Pliant Therapeutics, Inc. Depreciation for the twelve months ending March 31, 2024 was $1.9 M, a 4.51% increase year-over-year.
- Pliant Therapeutics, Inc. annual Depreciation for 2023 was $1.84 M, a 0.99% increase from 2022.
- Pliant Therapeutics, Inc. annual Depreciation for 2022 was $1.82 M, a 18.8% increase from 2021.
- Pliant Therapeutics, Inc. annual Depreciation for 2021 was $1.54 M, a 17.2% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)